Hangzhou Tigermed Consulting Co Ltd
SZSE:300347

Watchlist Manager
Hangzhou Tigermed Consulting Co Ltd Logo
Hangzhou Tigermed Consulting Co Ltd
SZSE:300347
Watchlist
Price: 67.94 CNY -0.83% Market Closed
Market Cap: 50.4B CNY
Have any thoughts about
Hangzhou Tigermed Consulting Co Ltd?
Write Note

Hangzhou Tigermed Consulting Co Ltd
Revenue

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Hangzhou Tigermed Consulting Co Ltd
Revenue Peer Comparison

Comparables:
603259
300759
2269
M
688114
W
2268

Competitive Revenue Analysis
Latest Figures & CAGR of Competitors

Company Revenue CAGR 3Y CAGR 5Y CAGR 10Y
Hangzhou Tigermed Consulting Co Ltd
SZSE:300347
Revenue
ÂĄ7B
CAGR 3-Years
23%
CAGR 5-Years
22%
CAGR 10-Years
33%
WuXi AppTec Co Ltd
SSE:603259
Revenue
ÂĄ38.7B
CAGR 3-Years
25%
CAGR 5-Years
28%
CAGR 10-Years
N/A
Pharmaron Beijing Co Ltd
SZSE:300759
Revenue
ÂĄ11.5B
CAGR 3-Years
23%
CAGR 5-Years
29%
CAGR 10-Years
N/A
WuXi Biologics (Cayman) Inc
HKEX:2269
Revenue
ÂĄ17.1B
CAGR 3-Years
28%
CAGR 5-Years
41%
CAGR 10-Years
N/A
M
MGI Tech Co Ltd
SSE:688114
Revenue
ÂĄ2.9B
CAGR 3-Years
2%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
W
WuXi XDC Cayman Inc
HKEX:2268
Revenue
ÂĄ2.1B
CAGR 3-Years
180%
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is Hangzhou Tigermed Consulting Co Ltd's Revenue?
Revenue
7B CNY

Based on the financial report for Jun 30, 2024, Hangzhou Tigermed Consulting Co Ltd's Revenue amounts to 7B CNY.

What is Hangzhou Tigermed Consulting Co Ltd's Revenue growth rate?
Revenue CAGR 10Y
33%

Over the last year, the Revenue growth was -2%. The average annual Revenue growth rates for Hangzhou Tigermed Consulting Co Ltd have been 23% over the past three years , 22% over the past five years , and 33% over the past ten years .

Back to Top